The first stop for professional medicines advice

Supply

46 results

Applied filters

Prescribing and using thiamine to prevent refeeding syndrome

2 May 2024Intravenous thiamine for prevention of refeeding syndrome should be reserved for those with intestinal failure where the oral or enteral route is unavailable.

Supply and administration of medicines by staff group (P to Z)

2 April 2024Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.

Supply and administration of medicines by staff group (H to O)

2 April 2024Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.

Supply and administration of medicines by staff group (A to G)

2 April 2024Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.

Supporting system response to the ADHD medicine shortage

16 November 2023Practical advice for the system in response to the NatPSA for Attention Deficit Hyperactivity Disorder (ADHD) medicines.

Continuing management of the ADHD medicines shortage

16 November 2023Support for the system in continuing to manage supply disruption of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD).

Prescribing and switching between modified-release methylphenidate

16 November 2023Modified-release methylphenidate capsules and tablets differ. Ensure patients receive appropriate treatment, particularly during periods of supply disruption.

Prescribing available medicines to treat ADHD

27 September 2023The availability of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD) varies currently. Supply content is maintained regularly by DHSC.

Prescribing GLP-1 receptor agonists

28 June 2023Glucagon-like peptide-1 (GLP-1) receptor agonist availability is resolved. Supply content is maintained by DHSC.

Understanding the falsified medicines directive

9 March 2023An overview of the changes to the requirements for medicines ‘safety features’ following the UK’s departure from the EU